These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 15086055)

  • 1. [Epidemiology and screening of colorectal cancer].
    Dancourt V; Faivre J
    Rev Prat; 2004 Jan; 54(2):135-42. PubMed ID: 15086055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mass screening for colorectal cancer].
    Faivre J; Tazi MA; Launoy G
    Rev Epidemiol Sante Publique; 1996; 44 Suppl 1():S7-14. PubMed ID: 8935859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colorectal cancer screening using fecal occult blood test and subsequent risk of colorectal cancer: a prospective cohort study in Japan.
    Lee KJ; Inoue M; Otani T; Iwasaki M; Sasazuki S; Tsugane S;
    Cancer Detect Prev; 2007; 31(1):3-11. PubMed ID: 17289293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Faecal occult blood screening and reduction of colorectal cancer mortality: a case-control study.
    Faivre J; Tazi MA; El Mrini T; Lejeune C; Benhamiche AM; Dassonville F
    Br J Cancer; 1999 Feb; 79(3-4):680-3. PubMed ID: 10027349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is it reasonable to use faecal occult blood test for colorectal cancer screening?
    Musil D; Tillich J
    Acta Univ Palacki Olomuc Fac Med; 1999; 142():119-21. PubMed ID: 10743740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for colorectal cancer.
    Mandel JS
    Curr Opin Gen Surg; 1994; ():79-84. PubMed ID: 7584018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Screening for colorectal cancer: what is the most effective strategy?].
    Merzenich H; Giersiepen K; Kieschke J; Zeeb H
    Gesundheitswesen; 2005 Nov; 67(11):803-8. PubMed ID: 16308813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal cancer mortality in two areas of Tuscany with different screening exposures.
    Costantini AS; Martini A; Puliti D; Ciatto S; Castiglione G; Grazzini G; Zappa M
    J Natl Cancer Inst; 2008 Dec; 100(24):1818-21. PubMed ID: 19066268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer.
    Lindholm E; Brevinge H; Haglind E
    Br J Surg; 2008 Aug; 95(8):1029-36. PubMed ID: 18563785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Screening and early diagnosis of colorectal cancer].
    Lepage C; Faivre J
    Rev Prat; 2010 Feb; 60(2):200-4. PubMed ID: 20225558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening of average-risk individuals for colorectal cancer. WHO Collaborating Centre for the Prevention of Colorectal Cancer.
    Winawer SJ; St John J; Bond J; Hardcastle JD; Kronborg O; Flehinger B; Schottenfeld D; Blinov NN
    Bull World Health Organ; 1990; 68(4):505-13. PubMed ID: 2208563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epidemiology and prevention of colorectal cancer].
    Faivre J; Pillon D; Michiels C
    Ann Gastroenterol Hepatol (Paris); 1992; 28(4):199-204. PubMed ID: 1444188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of colorectal cancer screening in Finland: experiences from the first three years of a public health programme.
    Malila N; Oivanen T; Hakama M
    Z Gastroenterol; 2008 Apr; 46 Suppl 1():S25-8. PubMed ID: 18368636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastric cancer after positive screening faecal occult blood testing and negative assessment.
    Zappa M; Visioli CB; Ciatto S; Grazzini G; Rubeca T; Bonanomi AG; Confortini M; Paci E; Castiglione G
    Dig Liver Dis; 2007 Apr; 39(4):321-6. PubMed ID: 17314076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mass screening of colorectal cancer by general practitioners in France: what is the real target population?].
    Desoubeaux N; Herbert C; Launoy G; Vallée JP; Bouvier V; Maurel J; Née E; Gignoux M
    Gastroenterol Clin Biol; 1997; 21(10):760-3. PubMed ID: 9587517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Arguments against implementing a population-based screening programme for colorectal cancer].
    Bonneux L
    Ned Tijdschr Geneeskd; 2008 Aug; 152(32):1777. PubMed ID: 18754310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospects for cancer control: colorectal cancer.
    Cox B; Sneyd M
    N Z Med J; 2005 Aug; 118(1221):U1632. PubMed ID: 16138170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 25-year follow-up of a population screened with faecal occult blood test in Finland.
    Malila N; Hakama M; Pukkala E
    Acta Oncol; 2007; 46(8):1103-6. PubMed ID: 17851857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal cancer screening with faecal occult blood test within a multiple disease screening programme: an experience from Keelung, Taiwan.
    Yang KC; Liao CS; Chiu YH; Yen AM; Chen TH
    J Med Screen; 2006; 13 Suppl 1():S8-13. PubMed ID: 17227635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fecal occult blood test and mass screening for colorectal cancer].
    Saito H; Soma Y; Kawaguchi H
    Gan To Kagaku Ryoho; 1991 Oct; 18(13):2232-40. PubMed ID: 1929443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.